Hospital Admissions / ABOUT THE IMS INSTITUTE / Healthcare Informatics IMS Institute / IMS Institute / /
IndustryTerm
retail pharmacies / healthcare / retail prescription copays / Nominal pharmaceutical spending / healthcare cost trends / insurance coverage / appropriate disease management / healthcare access / healthcare spending / healthcare system / retail drug use / health insurance / overall healthcare system / healthcare resources / population / healthcare services / healthcare costs / therapies for epilepsy / urther breakthrough products / /
MedicalCondition
rare diseases / COPD / HIV / prescription-bound cough / multiple myeloma / flu / Nervous system disorder / prescription allergy / Hepatitis C / multiple sclerosis / cystic fibrosis / very common skin cancers / autoimmune diseases / Osteoporosis Nervous System Disorders / cancers / both asthma / ADHD / cancer / disease / Chronic Obstructive Pulmonary Disease / •• The cough / mild allergy / allergy / pain / Gaucher’s disease / Parkinson’s disease / weaker cough / epilepsy / chronic myeloid leukemia / cough / either appropriate disease / /
MedicalTreatment
chemotherapy / day surgeries / /
Organization
IMS Institute / Centers for Disease Control and Prevention / Medicare / Murray Aitken Executive Director IMS Institute / U.S. Census Bureau / FDA / IMS Institute for Healthcare Informatics / /
Person
Naomi Sacks / Steve Gubernick / Bill McClellan / Michael Kleinrock / Tricare / Murray Aitken / / /
Position
Executive / Workman / Major / /
Product
Change In Prescriptions / Of Prescriptions / Dispensed Prescriptions / CHANGES IN THE UTILIZATION OF HEALTHCARE AND MEDICINES Prescriptions / /
May[removed]Declining Medicine Use and Costs: For Better or Worse? A Review of the Use of Medicines in the United States in 2012